Chris LoweEditor, Inner Circle

In 2001, Chris Lowe began his career in London as an analyst for financial markets news agency Reuters.

He later became an investigative financial reporter in his native Ireland. He worked for The Phoenix magazine, covering the real estate boom and bust there in the mid-2000s.

In 2007, Chris decided to “go independent.” He became an analyst at The Agora, the publishing firm founded by Bill Bonner in 1979.

With Bonner & Partners publisher Will Bonner (Bill’s eldest son), Chris helped launch Agora’s first foray into the Latin American market – a financial publishing project in Buenos Aires, Argentina.

Chris heads up our Legacy Inner Circle advisory, where he brings you the best money-making ideas from the Legacy team.

Chris is happiest when he’s traveling the world, tracking down new profit opportunities for readers. When he’s not on the road, he’s based in Lisbon, Portugal.

Chris Lowe’s Research Services

Legacy Inner Circle

Learn more

Blockchain Will Change the Whole Financial System

According to colleague Greg Wilson, the blockchain revolution that’s underway will also transform just about every facet of our society.

Crypto Will Be a Big Winner From the Metaverse Megatrend

In this week’s Weekly Pulse, Chris and Tom talk about the best way to play the new Metaverse megatrend.

Blockchain-Based Metaverse Worlds Will Share Profits With Users

Unlike Facebook’s business model, the future of the metaverse will be distributed, open, and accessible to all.

The CIA Is Piling Into Cybersecurity Tech

As hackers continue to steal sensitive information and disrupt critical infrastructure, it’s clear we need stronger protections.

Tech Royalties Can Ease Your Fears About Rising Inflation

This inflation “cure” can help you grow your wealth – potentially handing you explosive profits.

Tesla Will Head Lower Long Term

The rosy growth picture investors are betting on is almost certainly wrong.

Why the DEA Wants to Ramp Up Psychedelics Production

In this week’s Weekly Pulse, Chris and Tom talk about an exciting development in psychedelic medicine. After cracking down...